Stempeutics strives towards building a strong IP portfolio and is proactively engaged in extensive research in the area of stem cell technology and its application. As on date Stempeutics has filed 57 patents covering three products and across the globe.

Stempeucel® product has strong patent protection with more than 25 patent applications filed so far.
The patent estate includes


 a core process patent,


 a patent on technology for pooling of MSCs


 usage patents for multiple indications and a process improvement patent

These patents create a strong barrier to entry for the development of alternative pooled allogeneic stem cell products by competitors. The core patent has been filed in 18 countries, and has been granted in 14 countries including US, UK, France, Germany, Italy, Australia, New Zealand, Singapore, South Africa, China and Japan.

Stempeutron™ device has many novelties i.e. Flow thru' Gravity, Operations thru' Robotics Technology - deployed with unique algorithm for digestion process, Isolation thru' Filtration technology – for extraction of ready to use SVF of controlled composition and overall design with fewer moving parts and elimination of pumps , tubes etc. 5 IPs have been filed covering three core process i.e. flow/digestion/filtration. 5 design patents have been granted covering Agitation Container and sub system for processing Biological Samples.Stempeutron™ device patent has been granted in USA, Japan and South Korea

Stempeucare™ cosmetic product novelty is based on the unique process of generating the key ingredient i.e. conditioned medium containing relevant growth factors and cytokines critical for skin health. Conditioned medium is generated from a novel pooling process of the cells and conditioned medium - which reduces batch to batch variability. From a single cell banks more than 50 million units of end product can be produced using this novel technology.